Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis.
about
Prostaglandin D2 inhibits hair growth and is elevated in bald scalp of men with androgenetic alopeciaMechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cellsThe role of the EP receptors for prostaglandin E2 in skin and skin cancerMultifocal epithelial tumors and field cancerization: stroma as a primary determinantAltered prostanoid signaling contributes to increased skin tumorigenesis in Tpl2 knockout miceIL-17 mediated inflammation promotes tumor growth and progression in the skinAttenuation of UV-B exposure-induced inflammation by abalone hypobranchial gland and gill extracts.Non-surgical treatments of primary, non-melanoma eyelid malignancies: a review.COX-2 in liver, from regeneration to hepatocarcinogenesis: what we have learned from animal models?Effect of low-level laser therapy (660 nm) on the healing of second-degree skin burns in rats.Docosahexaenoic acid inhibits UVB-induced activation of NF-κB and expression of COX-2 and NOX-4 in HR-1 hairless mouse skin by blocking MSK1 signaling.Potential role of microsomal prostaglandin E synthase-1 in tumorigenesis.Kaempferol inhibits UVB-induced COX-2 expression by suppressing Src kinase activityTargeted deletion and lipidomic analysis identify epithelial cell COX-2 as a major driver of chemically induced skin cancerHumulone inhibits phorbol ester-induced COX-2 expression in mouse skin by blocking activation of NF-kappaB and AP-1: IkappaB kinase and c-Jun-N-terminal kinase as respective potential upstream targets.Hair follicular expression and function of group X secreted phospholipase A2 in mouse skin.7,3',4'-Trihydroxyisoflavone, a metabolite of the soy isoflavone daidzein, suppresses ultraviolet B-induced skin cancer by targeting Cot and MKK4.MLK3 is a novel target of dehydroglyasperin D for the reduction in UVB-induced COX-2 expression in vitro and in vivoCyclooxygenase 2 selective inhibitors in cancer treatment and prevention.Cyclooxygenase-2 and B-cell lymphoma-2 expression in cystitis glandularis and primary vesicle adenocarcinoma.Cystic duct dilatations and proliferative epithelial lesions in mouse mammary glands upon keratin 5 promoter-driven overexpression of cyclooxygenase-2.The role of COX-2 in intestinal inflammation and colorectal cancerLicochalcone A, a polyphenol present in licorice, suppresses UV-induced COX-2 expression by targeting PI3K, MEK1, and B-Raf.Apigenin prevents UVB-induced cyclooxygenase 2 expression: coupled mRNA stabilization and translational inhibition.The EP1 receptor for prostaglandin E2 promotes the development and progression of malignant murine skin tumorsCyclooxygenase 2-derived prostaglandin E2 regulates the angiogenic switchRole of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression.COX-2 inhibition in cancer therapeutics: a field of controversy or a magic bullet?Phloretin inhibits phorbol ester-induced tumor promotion and expression of cyclooxygenase-2 in mouse skin: extracellular signal-regulated kinase and nuclear factor-κB as potential targetsLoss of the platelet activating factor receptor in mice augments PMA-induced inflammation and cutaneous chemical carcinogenesisCharacterizing tumor-promoting T cells in chemically induced cutaneous carcinogenesisK-Ras and cyclooxygenase-2 coactivation augments intraductal papillary mucinous neoplasm and Notch1 mimicking human pancreas lesions.The eicosanoids leukotriene D4 and prostaglandin E2 promote the tumorigenicity of colon cancer-initiating cells in a xenograft mouse modelGenetic ablation of cyclooxygenase-2 in keratinocytes produces a cell-autonomous defect in tumor formation.Cyclooxygenase-2 expression is critical for chronic UV-induced murine skin carcinogenesisRAGE signaling sustains inflammation and promotes tumor development.Inflammatory events during murine squamous cell carcinoma development.What are cyclooxygenases and lipoxygenases doing in the driver's seat of carcinogenesis?Propyl gallate inhibits TPA-induced inflammation via the nuclear factor-κB pathway in human THP-1 monocytes.Non-steroid anti-inflammatory drugs, prostaglandins, and cancer.
P2860
Q24604475-8AF2FC76-10A5-48D0-AD0E-F35B72D5ED74Q24810540-59F04421-D555-4F36-96CB-D7257EB48232Q26999707-50565AE4-7FEB-4E4E-8050-8256226A0E8AQ27005678-972CB019-4B88-4803-8DFA-CBBAC37A8781Q28394475-04D53C24-5A55-4ED5-9253-8B2C243C844EQ28480915-AC9628B0-7691-4E41-8FC0-B5F011AAA1C4Q33598257-694A661C-9EA6-4132-8514-4C8CBCDA3EC0Q33735219-60FD87A1-6D91-45B6-B957-8BBCEC118B9CQ33756224-CB2F7A85-ABAC-4BB4-8F00-78E1098CB83CQ33966443-CB2C949A-695F-4E75-B86E-00A7CE040B1DQ34091232-FBFE6810-2ED7-49A5-9E01-9A2E1D0FDAA1Q34182494-23F4CEAD-1141-4D75-8212-C2329F5AD60DQ34279782-DB3850C0-54B7-44DA-A60C-502F941E52C3Q34518567-7C7D3AAB-68DA-4196-BC64-5BF9D8D48446Q34610297-2AB88385-2FA0-4567-8C38-3005393D00DDQ34719753-2C667903-4063-4453-974B-5BF14CB9F8A5Q34800201-635BD438-90F6-4586-968A-2006164981CDQ34885404-60CCF0D5-73B2-4D6D-9937-AC4B9323E71EQ35011895-0E07EC46-1E70-41F2-BBBC-0167156AB413Q35081466-6D8A1A6D-3BB5-425C-AADD-B3E9D907B257Q35083639-B9EB57A2-1191-4F00-8842-6802F084A307Q35234704-2D30BB1F-90EB-4E43-8AA7-7C54531D883FQ35380336-B13F270C-75AE-4110-B449-C9C40317DC27Q35641663-4169741E-E400-4AE7-884E-BA3FC8266162Q35722400-54DC5AC1-D56C-4841-B32A-A2A88CB7F10EQ35732971-8161DCD7-E56A-447C-B973-9A13A034CA40Q35735316-F0859D77-4A8D-487C-8C4A-FDD82B8F50D7Q35753467-157D6DB3-150C-4682-9755-36A09B367B46Q35765637-FAD14594-81F2-4B73-B9D4-4633D169779BQ35795383-18CBDF50-A566-42FE-A1FA-B15F7CAFBE58Q35800371-AC221C7E-B4DE-4D39-9636-6B0F7723675BQ36068611-22EE4917-6886-4D13-B517-3A40C683D934Q36070194-83790AFA-341D-42B5-B9D1-A2CA6328A8FFQ36401953-49D531A5-E0AD-43F9-9E87-394A79A31500Q36459962-3FB3B8B7-E273-429A-9151-BE6A6396FD26Q36502858-892A8BC9-77FA-47C8-83F1-F7F40AEBB729Q36523752-C044CD10-3EF1-4F6B-A286-AA0AAD2322CBQ36572139-DD6C776D-5C60-434E-9FFF-2E634D86CCF0Q36604033-2CCC73A8-EDA7-4212-BE65-7361DE51CFD9Q36689177-2D2FC5B5-B7DC-4E43-8F5F-C9A4581A301B
P2860
Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis.
@ast
Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis.
@en
Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis.
@nl
type
label
Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis.
@ast
Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis.
@en
Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis.
@nl
prefLabel
Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis.
@ast
Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis.
@en
Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis.
@nl
P2093
P2860
P356
P1476
Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis.
@en
P2093
Friedrich Marks
Gerhard Furstenberger
Gitta Neufang
Irina Berger
Karin Muller-Decker
Melanie Neumann
P2860
P304
12483-12488
P356
10.1073/PNAS.192323799
P407
P577
2002-09-09T00:00:00Z